| abstract |
Pharmaceutical formulations of fluoxetine hydrochloride suitable for manufacturing dispersible tablets by direct compression and comprising, in addition to fluoxetine hydrochloride, the appropriate excipients and coadjuvants, selected from among disintegrants, diluents, lubricants, anti-adherents, sweeteners, flavorings and, optionally, colorants. Said formulations are suitable for manufacturing dispersible tablets which disintegrate in less than three minutes in water at 19 DEG C-21 DEG C, and are appropriate for treatment of depression. |